Serum levels of C-peptide are associated with coronary artery calcification in patients with rheumatoid arthritis

Rheumatology International
Mathias BurgmaierVincent Brandenburg

Abstract

C-peptide has pro-atherogenic effects in animal models, and elevated C-peptide levels are associated with cardiovascular and all-cause mortality in patients undergoing coronary angiography. This cross-sectional study investigated the association between C-peptide serum levels and coronary artery calcification (CAC) in patients with rheumatoid arthritis (RA), a high-risk group for cardiovascular events. Fifty-four patients with RA were recruited from an arthritis outpatient department at the University Hospital in Aachen, Germany. CAC was measured by multi-slice CT scan, and blood samples were drawn from all patients for the analysis of C-peptide and other cardiovascular biomarkers. Mean serum levels of C-peptide (1.187 ± 0.771 vs 0.745 ± 0.481 nmol/L, p = 0.02), YKL-40, LDL cholesterol, and triglycerides were significantly higher in patients with CAC (n = 32, 59 %) compared to those without CAC (n = 22, 41 %). Univariate analysis revealed a significant association of C-peptide [OR 4.7, 95 % CI (1.1, 20.2)], YKL-40, triglycerides, hypertension, smoking, age, and male sex with the presence of CAC. After adjustment for body mass index, cholesterol, diabetes, adiponectin, calcium, and phosphate, C-peptide was still significantly as...Continue Reading

References

Mar 15, 1990·Journal of the American College of Cardiology·A S AgatstonR Detrano
May 31, 1973·The New England Journal of Medicine·G F Cahill
Aug 1, 1993·Arthritis and Rheumatism·L T JacobssonP H Bennett
Jan 14, 1999·The New England Journal of Medicine·R Ross
Apr 18, 2009·Cellular and Molecular Life Sciences : CMLS·M AleksicN Marx
Sep 30, 2009·Nature Reviews. Cardiology·Nikolaos Alexopoulos, Paolo Raggi
Dec 25, 2009·Journal of Atherosclerosis and Thrombosis·Egle CorradoSalvatore Novo
Oct 12, 2010·American Heart Journal·Willibald HochholzerRobert P Giugliano
Jan 13, 2011·Current Pharmaceutical Design·Ashley M Miller, Iain B McInnes
Jun 29, 2011·Journal of Cellular and Molecular Medicine·Dusica VasicDaniel Walcher
Jan 24, 2013·Arthritis Research & Therapy·Iván Ferraz-AmaroFederico Díaz-González
Jun 26, 2013·Rheumatology International·Aysegul Kucukali TurkyilmazFerhat Gokmen

❮ Previous
Next ❯

Citations

Dec 5, 2015·Frontiers in Immunology·Katharina Andrea SchuettMathias Burgmaier
Jan 31, 2017·International Journal of Immunopathology and Pharmacology·Mingshu SunJiaqi Qian
Oct 26, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Meghan A BowlerW David Merryman
May 1, 2021·International Journal of Molecular Sciences·Neža BrezovecKatja Lakota

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.